CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention
Abstract
Authors
C. Fornari M.G. Valsecchi S. Galimberti F. Madotto S. Conti L.G. Mantovani G. Cesana